0001104659-24-001492.txt : 20240104
0001104659-24-001492.hdr.sgml : 20240104
20240104201156
ACCESSION NUMBER: 0001104659-24-001492
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATEL DINESH V PH D
CENTRAL INDEX KEY: 0001120477
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 24514155
MAIL ADDRESS:
STREET 1: C/O PROTAGONIST THERAPEUTICS, INC.
STREET 2: 521 COTTONWOOD DRIVE, SUITE 100
CITY: MILPITAS
STATE: CA
ZIP: 95035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
tm241954-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-02
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001120477
PATEL DINESH V PH D
C/O PROTAGONIST THERAPEUTICS, INC.
7707 GATEWAY BLVD., SUITE 140
NEWARK
CA
94560-1160
1
1
0
0
President and CEO
0
Common Stock
2024-01-02
4
A
0
84875
0.00
A
619222
D
Stock Option (right to buy)
23.42
2024-01-02
4
A
0
315250
0.00
A
2034-01-02
Common Stock
315250
315250
D
Represents grant of restricted stock units payable solely in common stock that will vest in three equal annual installments on January 15, 2025, 2026 and 2027, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
/s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D.
2024-01-04